Medicine · Research topic

Open research questions in Phytochemicals and Antioxidant Activities

57 unresolved questions extracted from the limitations and future-work sections of 1,004 Phytochemicals and Antioxidant Activities papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Discover Chemistry (2026) 3:311 Page 14 of 20 bottlenecks, including variability in composition, low bioavailability, lack of standardiza- tion, and insufficient long-term human studies.

    Phytochemicals from natural sources classification physiological roles and health benefits · 2026 · DOI
  • 2 Future work Future studies should explore the effect of temperature, extraction time, and advanced extraction techniques, such as ultrasound- and microwave-assisted methods, to further enhance betalains recovery and stability. Additionally, the lack of interaction analysis between variables represents a limitation of this study. Firstly, the extraction experiments were conducted at a constant temper- ature (20 °C), and the influence of temperature variation on betalain stability and yield was not explored. Thirdly, the investigation was limited to a single cultivar (Beta vulgaris Cv.

    The efficacy of solvents, ascorbic acids, and pH on the yield of betacyanin and betaxanthin extraction compounds of Pablo beetroot · 2026 · DOI
  • AND FUTURE This review highlights quercetin as a key dietary flavonoid with broad pharmacological potential, anti-inflammatory, including antioxidant, anticancer, antidiabetic, cardioprotective, antiviral, neuroprotective, anti-obesity, anti-arthritic, wound-healing, immunomodulatory, and other beneficial effects demonstrated in extensive in vitro and in vivo studies. These pleiotropic actions arise from its ability to INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES 4047 | P a g e Arushi Shukla, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 4035-4050 | Review should to therefore modulate multiple signaling pathways, enzymes, transcription factors, and non-coding RNAs, positioning quercetin as a promising multi-target candidate for the prevention and management of diverse chronic diseases. However, clinical evidence is still limited compared with the robust preclinical data, and its poor aqueous solubility, rapid metabolism, and low oral bioavailability translation. Future remain major barriers research (i) prioritize well-designed, adequately powered clinical trials in specific disease settings; (ii) detailed elucidation of pharmacokinetics, metabolism, and long-term safety in humans; and (iii) rational development of advanced as nanoformulations, lipid-based carriers, polymeric nanoparticles, inclusion complexes—to enhance stability, tissue targeting, and systemic exposure. In parallel, dietary strategies that emphasise quercetin-rich foods, evidence-based standardized, together with nutraceutical support a formulations, may preventive, integrative approach to health. Overall, with continued interdisciplinary efforts, quercetin has the potential to move from a widely consumed nutraceutical to a clinically validated adjunct or lead compound in modern pharmacotherapy. systems—such micelles, delivery and REFERENCES 1. Abdulkarim, M. F., Abdullah, G. Z., Chitneni, M., Salman, I. M., Ameer, O. Z., Yam, M. F., et al. (2010). Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream.

    Quercetin: An Emerging Natural Flavonoid in Modern Therapeutics with Multifaceted Pharmacological Potential · 2026 · DOI
  • These findings should be interpreted as descriptive comparative observations rather than as statistically validated quantitative conclusions. The main limitations of the study include the absence of full systematic replication across all extraction conditions, the lack of particle-size standardization, the absence of additional analytical correction for residual moisture beyond oven drying to constant weight, the non-specific nature of the qualitative colorimetric phytochemical assays, and the tentative character of GC–MS compound assignment in the absence of external standards for formal confirmation. Accordingly, the present results provide a preliminary comparative framework rather than a predictive optimization model, and they should serve as a basis for future studies incorporating replicated experiments, standardized sample preparation, and quantitative targeted phytochemical analysis.

    Phytochemical Extraction from Mediterranean Plants: A Comparative Study of Traditional Techniques · 2026 · DOI
  • Bioactivity assays (antioxidant capacity, antimicrobial activity, anti-inflammatory potential) were not reported for the dried and packaged Bauhinia purpurea petal samples across storage timepoints, leaving the functional preservation of bioactive compounds unvalidated despite the focus on bioactivity in the title.

    Optimization of drying and packaging strategies for preserving phytochemicals, nutrients, and bioactivity in Bauhinia purpurea petals · 2026 · DOI
  • The cost-benefit analysis comparing freeze-drying at 40°C and 50°C versus cabinet drying and solar drying for Bauhinia purpurea petals was absent; energy consumption and economic viability data are needed for scaled production recommendations.

    Optimization of drying and packaging strategies for preserving phytochemicals, nutrients, and bioactivity in Bauhinia purpurea petals · 2026 · DOI
  • No sensory evaluation or organoleptic quality assessment (color, aroma, taste, texture) was conducted for dried Bauhinia purpurea petals across the five drying methods and four packaging systems over the three-month storage period, limiting real-world applicability for consumer acceptance.

    Optimization of drying and packaging strategies for preserving phytochemicals, nutrients, and bioactivity in Bauhinia purpurea petals · 2026 · DOI
  • Anti-nutritional compound changes (phytic acid, alkaloids, oxalates, tannins) showed high variability across packaging types, but the mechanistic basis for differential retention in plastic versus glass containers for Bauhinia purpurea petals was not investigated, limiting optimization of packaging material selection.

    Optimization of drying and packaging strategies for preserving phytochemicals, nutrients, and bioactivity in Bauhinia purpurea petals · 2026 · DOI
  • The study evaluated phytochemical retention across only three storage months (S1, S2, S3) for Bauhinia purpurea petals; extended storage stability beyond three months under the tested drying (solar, cabinet 40°C, cabinet 50°C, freeze-drying 40°C, freeze-drying 50°C) and packaging conditions (plastic bag, plastic bottle, aluminium foil bag, glass bottle) remains uncharacterized.

    Optimization of drying and packaging strategies for preserving phytochemicals, nutrients, and bioactivity in Bauhinia purpurea petals · 2026 · DOI
  • The paper documents quercetin's effects on endoplasmic reticulum stress-mediated oxidative stress and calcium channel activation in pancreatic β-cells, but dose-response and time-course studies characterizing the IC50 values for quercetin inhibition of endoplasmic reticulum stress markers (GRP78, CHOP, IRE1α) across physiological and pathological glucose concentrations in isolated human islet preparations versus rodent β-cell lines are absent.

    Quercetin in metabolic diseases: mechanisms, therapeutics, and multidimensional frontiers · 2026 · DOI
  • While the paper reviews quercetin's antidiabetic mechanisms in rodent models (streptozotocin-induced, db/db, high-fructose-fed rats), translation to human metabolic disease cohorts remains absent. Randomized controlled trials with quercetin nanoformulations in type 2 diabetic patients or obese individuals measuring insulin signaling biomarkers (phosphorylated Akt, glucose transporter expression), inflammatory cytokines (TNF-α, IL-6), and glucose homeostasis parameters are needed to establish clinical efficacy beyond animal models.

    Quercetin in metabolic diseases: mechanisms, therapeutics, and multidimensional frontiers · 2026 · DOI
  • Quercetin's protective effects against diabetic complications (cataract, nephropathy, encephalopathy) have been demonstrated via aldose reductase inhibition and TGF-β2/PI3K/Akt pathway modulation in individual rodent disease models, but cross-organ penetration studies assessing whether quercetin nanoformulations achieve therapeutic concentrations simultaneously in the lens, kidney glomeruli, and brain in multi-organ diabetic complications models have not been conducted.

    Quercetin in metabolic diseases: mechanisms, therapeutics, and multidimensional frontiers · 2026 · DOI
  • The current literature documents quercetin's inhibition of α-amylase and α-glucosidase enzymes and its effects on AMPK/TXNIP signaling and SIRT1/NLRP3 pathways in type 2 diabetes models, but mechanistic studies simultaneously measuring these enzymatic inhibition rates and downstream signaling cascade activation in the same high-fructose-fed or high-glucose-cultured cell systems remain incomplete. Quantitative kinetic analysis of quercetin's dual inhibitory potency against α-glucosidase in intestinal epithelial cells versus its SIRT1 activation in hypothalamic neurons is lacking.

    Quercetin in metabolic diseases: mechanisms, therapeutics, and multidimensional frontiers · 2026 · DOI
  • While quercetin liposomes, phytosomes, nanoemulsions, and hydrogel delivery systems have been individually evaluated for improved bioavailability in metabolic disease models, comparative efficacy studies directly contrasting these nanoencapsulation approaches in the same diabetic or obesity cohorts are absent. Head-to-head comparison of succinyl chitosan-stabilized liposomes versus whey protein isolate hydrogels versus lecithin phytosomes in streptozotocin-induced or db/db diabetic models is needed to establish which delivery system optimizes quercetin bioavailability and therapeutic outcomes.

    Quercetin in metabolic diseases: mechanisms, therapeutics, and multidimensional frontiers · 2026 · DOI
  • The extraction time reduction achieved in this study (97 min with optimized enzyme loadings) has not been benchmarked against industrially relevant processing scales; pilot-scale or industrial-scale validation of the multi-enzyme extraction protocol is needed to assess whether the synergistic effects and bioactive compound yields remain consistent when processing volumes increase from laboratory (gram-scale) to commercial production levels.

    Process optimization and predictive modeling of multi-enzyme extraction of bioactive compounds from Rosa canina L. · 2026 · DOI
  • The application of Box-Behnken Design (BBD) optimization to the multi-enzyme extraction system has not been validated across different Rosa canina L. cultivars and genotypes; the genetic variability observed in Liaudanskas et al. (antioxidant capacity ranging 188–397 µmol Trolox/g) suggests that cultivar-specific optimization parameters may be required for reproducible bioactive compound extraction.

    Process optimization and predictive modeling of multi-enzyme extraction of bioactive compounds from Rosa canina L. · 2026 · DOI
  • The standardization of antioxidant activity reporting across Rosa canina L. extraction studies requires conversion of reported values (expressed variously as mg Trolox/g, mg gallic acid/g, µmol Trolox/g) to enable direct numerical comparison; without a unified quantitative framework or conversion methodology, the comparative effectiveness of multi-enzyme extraction versus conventional and green extraction methods cannot be rigorously assessed.

    Process optimization and predictive modeling of multi-enzyme extraction of bioactive compounds from Rosa canina L. · 2026 · DOI
  • The synergistic matrix deconstruction mechanism of the four-enzyme system (Cellic® CTec3 HS, Viscoferm®, Pectinex® Ultra Color, Neutrase®) on Rosa canina L. pseudofruit cell walls has not been quantitatively validated; comparative enzymatic kinetics and structural analysis of cell wall degradation products at different time points are needed to confirm the proposed complementary action of cellulolytic, hemicellulolytic, pectinolytic, and proteolytic activities.

    Process optimization and predictive modeling of multi-enzyme extraction of bioactive compounds from Rosa canina L. · 2026 · DOI
  • The inconsistent antibacterial activity results against E. coli across different Rosa canina L. extraction methods (MIC values ranging from 4 mg/mL to >512 mg/mL) cannot be resolved without detailed phytochemical profiling using LC–MS/MS to identify which specific bioactive compounds responsible for antibacterial activity are differentially extracted by cellulolytic, hemicellulolytic, pectinolytic, and proteolytic enzyme combinations.

    Process optimization and predictive modeling of multi-enzyme extraction of bioactive compounds from Rosa canina L. · 2026 · DOI
  • The weak α-amylase inhibition observed in the enzymatic-assisted extraction (EAE) of Rosa canina L. requires investigation of the specific mechanisms causing reduced activity, including structural changes to phenolics during enzymatic hydrolysis, co-extracted polysaccharide interference, and the relative abundance of phenolic subclasses with low inhibitory potential. Detailed analysis is needed to differentiate which factors primarily contribute to the diminished antidiabetic activity despite increased total phenolic and flavonoid yields.

    Process optimization and predictive modeling of multi-enzyme extraction of bioactive compounds from Rosa canina L. · 2026 · DOI
  • Collectively, current evidence supports the multifaceted role of anthocyanins in cardiovascular protection. While their low bioavailability has traditionally been viewed as a limitation, it is now evident that their extensive transformation into active metabolites via host and microbial metabolism enables broad systemic effects. These effects are mediated by improvements in endothelial function, reduction in oxidative stress, and attenuation of inflammatory signalling, all of which are relevant to atherosclerosis and hypertension. Future research should aim to identify the most potent anthocyanin-derived metabolites and uncover their specific mechanisms of action. Additionally, it is important to elucidate how individual microbiota profiles influence the metabolism and efficacy of anthocyanins. Investigating dietary and probiotic strategies to enhance the microbial bioconversion of anthocyanins could further optimize their therapeutic potential. Finally, translating preclinical findings into well-controlled human intervention studies with standardized anthocyanin dosing and precise tracking of resulting metabolites will be essential for confirming their clinical relevance and efficacy. Ultimately, anthocyanins may be most accurately viewed as prodrugs whose cardiovascular benefits rely on a complex interplay between host metabolism and gut microbial activity. Recognizing this dynamic offers a new perspective on dietary polyphenols opening the door to personalized nutrition strategies aimed at enhancing vascular health. AUTHOR CONTRIBUTION The study was conceptualised and designed by Liyana Nursyahirah Johari and Wan Amir Nizam Wan Ahmad. Resource acquisition was carried out by Liyana Nursyahirah Johari and Wan Amir Nizam Wan Ahmad. The manuscript was reviewed by Liza Noordin and Wan Amir Nizam Wan Ahmad. Final approval of the manuscript was done by Wan Amir Nizam Wan Ahmad and Liza Noordin. ETHIS APPROVAL Not applicable. CONFLICT OF INTEREST The authors declare no conflicts of interest in this work. ACKNOWLEDGEMENTS This work was supported by the Ministry of Higher Education, Malaysia, under the Fundamental Research Grant Scheme (FRGS) (Project code: FRGS/1/2024/SKK15/USM/02/4). REFERENCES Abouzahra, A., Sabraoui, A., & Afdel, K. (2020). Model composition in Model Driven Engineering: A systematic literature review. In Information and Software Technology, 125, 106316. https://doi.org/10.1016/j.infsof.2020.106316 Alam, M. A., Islam, P., Subhan, N., Rahman, M. M., Khan, F., Burrows, G. E., Nahar, L., & Sarker, S. D. (2021). Potential health benefits of anthocyanins in oxidative stress related disorders. Phytochemistry Reviews, 20(4), 705–749. https://doi.org/10.1007/s11101-021-09757-1 Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa Carvalho, F., Lahlou, R. A., & Silva, L. R. (2024). Phenolic Compounds from Cherries and Berries for Chronic Disease Management and Cardiovascular Risk Reduction. In Nutrients, (16), 11.

    Anthocyanin metabolism and vasorelaxant activity in cardiovascular related diseases: A systematic literature review · 2026 · DOI
  • and MAPK-driven Taxifolin exhibits a broad spectrum of pharmacological activities, including antioxidant, anti-inflammatory, anticancer, neuroprotective, hepatoprotective, antidiabetic, cardioprotective, and nephroprotective effects. These activities are mediated through a limited number of interconnected molecular pathways, most notably activation of the Nrf2/HO-1 antioxidant axis, inflammatory suppression of NF-κBsignaling, regulation of apoptosis and mitochondrial function, and modulation of metabolic pathways such as PI3K/Akt and AMPK. Collectively, these mechanisms provide a coherent biological framework underlying taxifolin’s reported effects across diverse disease models. Future should prioritize mechanistically driven and clinically relevant models to better characterize the therapeutic potential of taxifolin. Evaluating nanoformulations or advanced delivery systems may also help overcome improve translational potential.

    Exploring the therapeutic potential of naturally occurring taxifolin, a dietary flavonoid: an updated comprehensive review · 2026 · DOI
  • In general, this paper provides comprehensive review of the sources and compositions of dietary polyphenols from plant materials, and presents an overview of the evidence on dietary polyphenols against chronic diseases, which may offer some constructive inspirations for further research on dietary polyphenols and industrial application in the food and medicine industry.

    Research progress on classification, sources and functions of dietary polyphenols for prevention and treatment of chronic diseases · 2023 · DOI
  • Antihypertensive activity of natural antioxidant, olive leaf extract (OLE) is known, but its influence on cardiovascular system when administered in a high dose has not been investigated yet.

    Effects of high dose olive leaf extract on haemodynamic and oxidative stress parameters in normotensive and spontaneously hypertensive rats · 2014 · DOI
  • Further phytochemical characterization and mechanistic studies are warranted to identify the active constituents and validate their therapeutic potential for lung cancer management.

    Anthocyanin Quantification and In Vitro Anticancer Activity of Alpinia purpurata Flower Extract Against Human Lung Adenocarcinoma (A549) Cells · 2026 · DOI

Most-cited papers in Phytochemicals and Antioxidant Activities

Most recent work

Find a gap in your own Phytochemicals and Antioxidant Activities sub-topic

This page shows what the Phytochemicals and Antioxidant Activities literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

57 open questions have been extracted from the limitations and future-work passages of 1,004 Phytochemicals and Antioxidant Activities papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Compare the categoryHonest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.